[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North America Advanced Wound Care Market

September 2017 | 150 pages | ID: N99CE844B35EN
Data Bridge Market Research

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this region, The North America advanced wound care market is projected to reach USD 11,148.2 million by 2024, from USD 5,993.6 million in 2016 growing at a CAGR of 8.1% in the forecast period 2017 to 2024.

Based on geography, the North America advanced wound care market is segmented into 5 geographical regions, such as,
  • U.S.
  • Mexico,
  • Canada,
North America advanced wound care market competition by top players including
  • 3M,
  • Smith and Nephew,
  • Medtronic,
  • Acelity L.P. INC,
  • Molnlycke Healthcare AB,
  • Convatec Inc.,
  • Baxter,
  • ColoplaHst,
  • Ethicon. Inc,
  • Hollister Inc,
  • Integra Life Sciences Corporation,
  • Derma Sciences Inc,
  • Spiracur Inc,
  • Medline Industries,
  • Mimedx Group,
  • Organogenesis Inc,
  • Talley Group,
  • BSN Medical,
  • Devon Medical Products,
  • Human Biosciences Inc,
  • B.Braun Melsungen AG,
  • Cardinal Health,
  • Paul Hartmann Limited,
  • DeRoyal Industries Inc,
  • DermaRite Industries, LLC,
  • MPM Medical Inc,
  • Kinetic Concepts,
The North America advanced wound care market is segmented into three product types, namely, dressing, biologics, and therapy devices.

Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing.

Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.

Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF).

Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyberbaric oxygen chambers and physical therapies.

Based on NPWT type, the market is segmented into stand alone NPWT devices, portable NPWT devices and disposable NPWT devices.

Based on PRD type, the market is segmented into mattress and bed.

Based on hyberbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.

Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, mechanical among others.

Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.

Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, venous ulcer among others.

On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare. On the basis of end user the market is segmented into direct tenders, and retails.

On the basis of distribution channel the market is segmented into direct tenders, and retails.
1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL ADVANCED WOUND CARE MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS
  3.1.1. RISING AGING AND GERIATRIC POPULATION
  3.1.2. TECHNOLOGICAL ADVANCEMENT
  3.1.3. GOVERNMENT SUPPORT
  3.1.4. RISING INCIDENCES OF CHRONIC WOUND
  3.1.5. INCREASING TREND
3.2. RESTRAINTS
  3.2.1. LOW AWARENESS
  3.2.2. SLOW GROWTH RATE AND SHRINKING MARKET
  3.2.3. COMPLEX REGULATORY APPROVAL PROCESS
  3.2.4. COMPETITION WITH OTHER MOIST DRESSINGS
3.3. OPPORTUNITIES
  3.3.1. REIMBURSEMENT
  3.3.2. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
  3.3.3. UNMET NEED
  3.3.4. INCREASING DEMAN
3.4. CHALLENGE
  3.4.1. SHORTAGE OF TRAINED STAFF
  3.4.2. THE DEVELOPMENT OF SUBSTITUTE PRODUCTS
3.5. KEY MARKET TRENDS AND UPCOMMING TECHNOLOGIES
  3.5.1. SMART DRESSING WILL PUSH FUTURE GROWTH
  3.5.2. HYDROFIBER HAS BEEN THE MOST SIGNIFICANT RECENT INNOVATION
  3.5.3. ALGINATE DRESSING IS EXPECTED TO GROW ROBUSTLY IN THE UPCOMING YEARS
  3.5.4. FOAM DRESSING ACCOUNTING THE LARGEST MARKET SEGMENT IN THE UPCOMING YEARS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

6.1. OVERVIEW
6.2. DRESSING
6.3. BIOLOGICS
6.4. THERAPY DEVICES

7. GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE

7.1. INTRODUCTION
7.2. SURGICAL WOUND
  7.2.1. CLASS I
  7.2.2. CLASS II
  7.2.3. CLASS III
  7.2.4. CLASS IV
7.3. DIABETIC ULCERS
7.4. PRESSURE ULCERS
7.5. VENOUS ULCERS
7.6. BURNS

8. GLOBAL ADVANCED WOUND CARE MARKET, BY END USER

8.1. OVERVIEW

9. GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

9.1. OVERVIEW

10. GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

10.1. OVERVIEW
10.2. NORTH AMERICA ADVANCED WOUND CARE MARKET
  10.2.1. U.S. ADVANCED WOUND CARE MARKET
  10.2.2. CANADA ADVANCED WOUND CARE MARKET
  10.2.3. MEXICO ADVANCED WOUND CARE MARKET

11. GLOBAL ADVANCED WOUND CARE MARKET, COMPANY SHARE

11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)
11.5. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
11.6. COMPANY SHARE ANALYSIS: SOUTH AMERICA

12. COMPANY PROFILES

12.1. ACELITY L.P. INC.
  12.1.1. COMPANY OVERVIEW
  12.1.2. REVENUE ANALYSIS
  12.1.3. PRODUCT PORTFOLIO
  12.1.4. RECENT DEVELOPMENTS
12.2. SMITH AND NEPHEW
  12.2.1. COMPANY OVERVIEW
  12.2.2. REVENUE ANALYSIS
  12.2.3. PRODUCT PORTFOLIO
  12.2.4. RECENT DEVELOPMENTS
12.3. MOLNLYCKE HEALTHCARE
  12.3.1. COMPANY OVERVIEW
  12.3.2. REVENUE ANALYSIS
  12.3.3. PRODUCT PORTFOLI
  12.3.4. RECENT DEVELOPMENTS
12.4. CONVATEC INC.
  12.4.1. COMPANY OVERVIEW
  12.4.2. REVENUE ANALYSIS
  12.4.3. PRODUCT PORTF
  12.4.4. RECENT DEVELOPMENTS
12.5. 3M
  12.5.1. COMPANY OVERVIEW
  12.5.2. REVENUE ANALYSIS
  12.5.3. PRODUCT PORTFOLIO
  12.5.4. RECENT DEVELOPMENTS
12.6. BAXTER
  12.6.1. COMPANY OVERVIEW
  12.6.2. REVENUE ANALYSIS
  12.6.3. PRODUCT PORTFOLIO
  12.6.4. RECENT DEVELOPMENTS
12.7. COLOPLAST
  12.7.1. COMPANY OVERVIEW
  12.7.2. REVENUE ANALYSIS
  12.7.3. PRODUCT PORTFOLIO
  12.7.4. RECENT DEVELOPMENTS
12.8. ETHICON INC
  12.8.1. COMPANY OVERVIEW
  12.8.2. REVENUE ANALYSIS
  12.8.3. PRODUCT PORTFOLIO
  12.8.4. RECENT DEVELOPMENTS
12.9. INTEGRA LIFE SCIENCES CORPORATION
  12.9.1. COMPANY OVERVIEW
  12.9.2. REVENUE ANALYSIS
  12.9.3. PRODUCT PORTFOLIO
  12.9.4. RECENT DEVELOPMENTS
12.10. DERMA SCIENCES INC
  12.10.1. COMPANY OVERVIEW
  12.10.2. REVENUE ANALYSIS
  12.10.3. PRODUCT PORTFOLIO
  12.10.4. RECENT DEVELOPMENTS
12.11. PAUL HARTMANN LIMITED
  12.11.1. COMPANY OVERVIEW
  12.11.2. REVENUE ANALYSIS
  12.11.3. PRODUCT PORTFOLIO
12.12. ORGANOGENESIS INC
  12.12.1. COMPANY OVERVIEW
  12.12.2. REVENUE ANALYSIS
  12.12.3. PRODUCT PORTFOLIO
  12.12.4. RECENT DEVELOPMENTS

13. RELATED REPORTS

TABLE LIST

TABLE 1 NORTH AMERICA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 NORTH AMERICAADVANCED WOUND CARE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 3 NORTH AMERICA ADVANCED WOUND CARE DRESSING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 4 NORTH AMERICA ADVANCED WOUND CARE BIOLOGICS MARKET, BY PRODUCTTYPE, 2015 – 2024 (USD MILLION)
TABLE 5 NORTH AMERICA ADVANCED WOUND CARE GROWTH FACTOR MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 6 NORTH AMERICA ADVANCED WOUND CARE THERAPY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 7 NORTH AMERICA ADVANCED WOUND CARE NEGATIVE PRESSURE WOUND THERAPY (NPWT)MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 8 NORTH AMERICA ADVANCED WOUND CAREPRESSURE RELIEF DEVICES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 9 NORTH AMERICA ADVANCED WOUND CARE HYPRBARIC OXYGEN CHAMBERS, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 10 NORTH AMERICA ADVANCED WOUND CARE WOUND DEBRIDEMENT DEVICES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 11 NORTH AMERICA ADVANCED WOUND CARE PHYSICAL THERAPIES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 12 NORTH AMERICA ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2015 – 2024 (USD MILLION)
TABLE 13 NORTH AMERICA ADVANCED WOUND CARE MARKET, BY END USER, 2015 – 2024 (USD MILLION)
TABLE 14 NORTH AMERICA ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
TABLE 15 U.S. ADVANCED WOUND CARE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 16 U.S. ADVANCED WOUND CARE DRESSING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 17 U.S. ADVANCED WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 18 U.S. ADVANCED WOUND CARE GROWTH FACTOR MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 19 U.S. ADVANCED WOUND CARE THERAPY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 20 U.S. ADVANCED WOUND CARE NEGATIVE PRESSURE WOUND THERAPY (NPWT)MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 21 U.S. ADVANCED WOUND CARE PRESSURE RELIEF DEVICES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 22 U.S. ADVANCED WOUND CARE HYPRBARIC OXYGEN CHAMBERS, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 23 U.S. ADVANCED WOUND CARE WOUND DEBRIDEMENT DEVICES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 24 U.S. ADVANCED WOUND CARE PHYSICAL THERAPIES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 25 U.S. ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2015 – 2024 (USD MILLION)
TABLE 26 U.S. ADVANCED WOUND CARE MARKET, BY END USER, 2015 – 2024 (USD MILLION)
TABLE 27 U.S. ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
TABLE 28 CANADA ADVANCED WOUND CARE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 29 CANADA ADVANCED WOUND CARE DRESSING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 30 CANADA ADVANCED WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 31 CANADA ADVANCED WOUND CARE GROWTH FACTOR MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 32 CANADA ADVANCED WOUND CARE THERAPY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 33 CANADA ADVANCED WOUND CARE NEGATIVE PRESSURE WOUND THERAPY (NPWT)MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 34 CANADA ADVANCED WOUND CARE PRESSURE RELIEF DEVICES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 35 CANADA ADVANCED WOUND CARE HYPERBARIC OXYGEN CHAMBERS, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 36 CANADA ADVANCED WOUND CARE WOUND DEBRIDEMENT DEVICES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 37 CANADA ADVANCED WOUND CARE PHYSICAL THERAPIES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 38 CANADA ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2015 – 2024 (USD MILLION)
TABLE 39 CANADA ADVANCED WOUND CARE MARKET, BY END USER, 2015 – 2024 (USD MILLION)
TABLE 40 CANADA ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
TABLE 41 MEXICO ADVANCED WOUND CARE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 42 MEXICO ADVANCED WOUND CARE DRESSING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 43 MEXICO ADVANCED WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 44 MEXICO ADVANCED WOUND CARE GROWTH FACTOR MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 45 MEXICO ADVANCED WOUND CARE THERAPY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 46 MEXICO ADVANCED WOUND CARE NEGATIVE PRESSURE WOUND THERAPY (NPWT)MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 47 MEXICO ADVANCED WOUND CARE PRESSURE RELIEF DEVICES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 48 MEXICO ADVANCED WOUND CARE HYPERBARIC OXYGEN CHAMBERS, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 49 MEXICO ADVANCED WOUND CARE WOUND DEBRIDEMENT DEVICES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 50 MEXICO ADVANCED WOUND CARE PHYSICAL THERAPIES, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 51 MEXICO ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2015 – 2024 (USD MILLION)
TABLE 52 MEXICO ADVANCED WOUND CARE MARKET, BY END USER, 2015 – 2024 (USD MILLION)
TABLE 53 MEXICO ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)

FIGURES LIST

FIGURE 1 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR GLOBAL ADVANCED WOUND CARE MARKET IN 2016 AND APAC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024

COMPNIES PROFILES

3M, Smith and Nephew, Medtronic, Acelity L.P. INC, Molnlycke Healthcare AB, Convatec Inc., Baxter, ColoplaHst, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, Mimedx Group, Organogenesis Inc, Talley Group, BSN Medical, Devon Medical Products, Human Biosciences Inc, B.Braun Melsungen AG, Cardinal Health, Paul Hartmann Limited, DeRoyal Industries Inc, DermaRite Industries, LLC, MPM Medical Inc, Kinetic Concepts


More Publications